Phthalylsulfathiazole

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Phthalylsulfathiazole is a sulfonamide antibacterial indicated in the treatment of gastrointestinal infections.

Generic Name
Phthalylsulfathiazole
DrugBank Accession Number
DB13248
Background

Phthalylsulfathiazole is a broad spectrum antibiotic which is part of the drug class, sulfonamides. It was used as an antibiotic for bowel surgery, and for infections of the colon 1.

Type
Small Molecule
Groups
Approved
Structure
Thumb
Weight
Average: 403.43
Monoisotopic: 403.029662879
Chemical Formula
C17H13N3O5S2
Synonyms
  • Phthalylsulfathiazole

Pharmacology

Indication

Not Available

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Associated Conditions
Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcarboseThe therapeutic efficacy of Acarbose can be increased when used in combination with Phthalylsulfathiazole.
AcetohexamideThe therapeutic efficacy of Acetohexamide can be increased when used in combination with Phthalylsulfathiazole.
AlbiglutideThe therapeutic efficacy of Albiglutide can be increased when used in combination with Phthalylsulfathiazole.
AlogliptinThe therapeutic efficacy of Alogliptin can be increased when used in combination with Phthalylsulfathiazole.
BenzylpenicillinPhthalylsulfathiazole may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.
BromocriptineThe therapeutic efficacy of Bromocriptine can be increased when used in combination with Phthalylsulfathiazole.
CanagliflozinThe therapeutic efficacy of Canagliflozin can be increased when used in combination with Phthalylsulfathiazole.
ChlorpropamideThe therapeutic efficacy of Chlorpropamide can be increased when used in combination with Phthalylsulfathiazole.
CholestyramineCholestyramine can cause a decrease in the absorption of Phthalylsulfathiazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
ColesevelamColesevelam can cause a decrease in the absorption of Phthalylsulfathiazole resulting in a reduced serum concentration and potentially a decrease in efficacy.
Interactions
Improve patient outcomes
Build effective decision support tools with the industry’s most comprehensive drug-drug interaction checker.
Learn more
Food Interactions
Not Available

Products

Products
Comprehensive & structured drug product info
From application numbers to product codes, connect different identifiers through our commercial datasets.
Learn more
Easily connect various identifiers back to our datasets
Learn more
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
ไดฟูลินPhthalylsulfathiazole (250 mg) + Diiodohydroxyquinoline (250 mg) + Furazolidone (50 mg) + Kaolin (250 mg) + Neomycin sulfate (50 mg)Tabletบริษัท เอเชี่ยนยูเนี่ยนแล็บบอราตอรี่ จำกัด จำกัด1988-12-072020-07-19Thailand flag
ไดเซนโตPhthalylsulfathiazole (250 MG) + Diiodohydroxyquinoline (250 MG) + Furazolidone (50 MG) + Kaolin (250 MG) + Neomycin (50 MG)Tabletบริษัท แอดวานซ์ ฟาร์มาซูติคอล แมนูเฟคเจอริ่ง จำกัด2013-11-08Not applicableThailand flag

Categories

ATC Codes
G01AE10 — Combinations of sulfonamidesA07AB02 — Phthalylsulfathiazole
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as benzanilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with a benzene ring. They have the general structure RNC(=O)R', where R,R'= benzene.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Anilides
Direct Parent
Benzanilides
Alternative Parents
Benzenesulfonamides / Benzamides / Benzenesulfonyl compounds / Benzoic acids / Benzoyl derivatives / Organosulfonamides / Thiazoles / Aminosulfonyl compounds / Heteroaromatic compounds / Secondary carboxylic acid amides
show 8 more
Substituents
Aminosulfonyl compound / Aromatic heteromonocyclic compound / Azacycle / Azole / Benzamide / Benzanilide / Benzenesulfonamide / Benzenesulfonyl group / Benzoic acid / Benzoic acid or derivatives
show 21 more
Molecular Framework
Aromatic heteromonocyclic compounds
External Descriptors
sulfonamide, 1,3-thiazole, dicarboxylic acid monoamide (CHEBI:9336)
Affected organisms
Not Available

Chemical Identifiers

UNII
6875L5852V
CAS number
85-73-4
InChI Key
PBMSWVPMRUJMPE-UHFFFAOYSA-N
InChI
InChI=1S/C17H13N3O5S2/c21-15(13-3-1-2-4-14(13)16(22)23)19-11-5-7-12(8-6-11)27(24,25)20-17-18-9-10-26-17/h1-10H,(H,18,20)(H,19,21)(H,22,23)
IUPAC Name
2-({4-[(1,3-thiazol-2-yl)sulfamoyl]phenyl}carbamoyl)benzoic acid
SMILES
OC(=O)C1=CC=CC=C1C(=O)NC1=CC=C(C=C1)S(=O)(=O)NC1=NC=CS1

References

General References
  1. STREICHER MH: Phthalylsulfathiazole (sulfathialidine); clinical, chemical and bacteriologic evaluations in infectious diseases of the colon. J Am Med Assoc. 1945 Dec 15;129:1080-3. [Article]
  2. FDA Thailand: Dichlorrhea (Furazolidone, Metronidazole, and Phthalylsulfathiazole) Oral Tablet [Link]
KEGG Compound
C07659
ChemSpider
4641
RxNav
33632
ChEBI
9336
ChEMBL
CHEMBL1524273
ZINC
ZINC000001530877
Wikipedia
Phthalylsulfathiazole

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Tablet
Tablet
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.0171 mg/mLALOGPS
logP2.22ALOGPS
logP2.55ChemAxon
logS-4.4ALOGPS
pKa (Strongest Acidic)2.91ChemAxon
pKa (Strongest Basic)0.59ChemAxon
Physiological Charge-2ChemAxon
Hydrogen Acceptor Count6ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area125.46 Å2ChemAxon
Rotatable Bond Count5ChemAxon
Refractivity100.36 m3·mol-1ChemAxon
Polarizability37.83 Å3ChemAxon
Number of Rings3ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available
LC-MS/MS Spectrum - LC-ESI-qTof , PositiveLC-MS/MSNot Available
MS/MS Spectrum - , positiveLC-MS/MSsplash10-052b-3940000000-92fc3db27cdfa654a5fd

Drug created on June 23, 2017 20:38 / Updated on June 05, 2021 09:13